The Law Offices of Frank R. Cruz is reaching out to investors regarding a potential investigation into Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) for possible violations of federal securities laws. If you are a shareholder who has experienced a loss, you’re encouraged to participate in the investigation by clicking here.
On August 3, 2023, the U.S. Food and Drug Administration (“FDA”) granted Zydus Lifesciences Limited (“Zydus”) approval and 180-day Competitive Generic Therapies exclusivity for a generic version of Gralise, a product marketed by Assertio. This approval allows Zydus to exclusively market their generic version of Gralise for 180 days, potentially impacting Assertio’s financial performance.
The investigation by the Law Offices of Frank R. Cruz aims to determine whether Assertio and its executives violated federal securities laws by not disclosing to investors the impact of Zydus’ approval on the Company’s business and financial condition. If it is found that Assertio failed to provide this information, they may be held accountable for any potential harm suffered by shareholders as a result of this omission.
If you are an investor who has experienced a financial loss due to your investment in Assertio Holdings, Inc., the Law Offices of Frank R. Cruz would like to hear from you. You have the opportunity to participate in the investigation by clicking the link provided and providing any relevant information.
The Law Offices of Frank R. Cruz is a highly respected firm with a track record of success in pursuing securities litigation on behalf of shareholders. Their aim is to protect the rights of investors and hold companies accountable for any potential breaches of federal securities laws.
If you have suffered a loss as a shareholder of Assertio Holdings, Inc. and believe that the Company may not have disclosed important information regarding Zydus’ approval and its potential impact on the Company’s financial performance, you are encouraged to participate in the investigation. Your input is valuable and could be crucial in determining the course of action in holding Assertio accountable for any potential harm suffered by shareholders.
The Law Offices of Frank R. Cruz is dedicated to ensuring that investors are treated fairly and that companies are held responsible for any potential violations of federal securities laws. Your participation in the investigation is essential in achieving this goal and seeking justice for shareholders who have experienced a loss due to Assertio’s alleged misconduct.
For more information about the investigation into Assertio Holdings, Inc. and to participate in the process, please click here. Your voice as a shareholder is important, and the Law Offices of Frank R. Cruz is committed to representing your interests in this matter.
Source link
